Home
About
Directory
Promoted Listings
Purchase Data
Drug Pipelines
Data Licensing
Newsletter
Contact
Cadence Pharmaceuticals
is defunct.
Acquired by Mallinckrodt, Mar 2014, $1.4B
------------------
If you believe any of this information is incorrect, please
let us know
.